PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how the Pacifier Activated Lullaby (PAL) device might assist preterm infants with chronic lung disease in starting to feed by mouth. The PAL plays music when the baby sucks on a pacifier, encouraging better sucking skills. Babies in the trial will either receive this music therapy or be in a no-contact group. Ideal candidates are infants born before 33 weeks who are stable enough to hear sounds but require breathing assistance that prevents oral feeding. As an unphased trial, this study provides a unique opportunity for infants to potentially benefit from innovative music therapy while contributing to groundbreaking research.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that the Pacifier Activated Lullaby (PAL) intervention is safe for infants with chronic lung disease?
Research has shown that the Pacifier Activated Lullaby (PAL) is safe for preterm babies. Studies have examined its effects and found no major safety issues. The FDA has approved the PAL device, confirming it meets safety standards for use in neonatal intensive care units (NICUs). Additionally, a similar music-playing pacifier improved feeding skills without causing stress or growth problems in babies. These findings suggest that infants generally tolerate the PAL well.12345
Why are researchers excited about this trial?
Researchers are excited about the Pacifier Activated Lullaby (PAL) intervention because it offers a unique approach to improving oral feeding in infants with chronic lung disease. Unlike traditional methods, which may rely on gradually introducing oral feeds or using different feeding techniques, PAL uses music as positive reinforcement. This innovative device connects to an infant's pacifier and plays soothing music when it detects sucking, encouraging better feeding habits. This method not only aims to enhance sucking skills but also provides a comforting and engaging experience for infants, potentially leading to faster transitions to oral feeding.
What evidence suggests that the Pacifier Activated Lullaby (PAL) intervention is effective for improving oral feeding in preterm infants with chronic lung disease?
Research has shown that the Pacifier Activated Lullaby (PAL) can help preterm infants learn to feed by mouth more effectively. In this trial, infants in the experimental group will receive the PAL intervention. The device plays music when the baby sucks on a pacifier, improving their sucking skills. One study found that a similar music-playing pacifier with a mother's voice reduced the time babies needed tube feeding, without causing stress or affecting growth. These early findings suggest that PAL might improve feeding skills in infants with chronic lung disease.12345
Are You a Good Fit for This Trial?
This trial is for preterm infants with chronic lung disease and respiratory distress syndrome who need non-invasive breathing support and can handle a little bit of sound. They should be born before 33 weeks of pregnancy and enrolled before reaching 35 weeks. Babies with certain bowel issues, on invasive breathing support, in other music therapy studies, or without any respiratory support are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Infants in the experimental group receive the PAL intervention 2 times a week until they transition to room air or <2L high flow nasal cannula and begin oral feeding attempts.
Control
Infants in the control group do not receive any music therapy intervention throughout NICU admission.
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on the transition to oral feeding and respiratory support.
What Are the Treatments Tested in This Trial?
Interventions
- Pacifier Activated Lullaby (PAL) intervention
Pacifier Activated Lullaby (PAL) intervention is already approved in United States for the following indications:
- Improving oral feeding in preterm infants with chronic lung disease and respiratory distress syndrome
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
University of Georgia
Collaborator